REHABILITATION STRATEGIES FOLLOWING ENDOMETRIAL CANCER TREATMENT: EXPLORING CONTEMPORARY APPROACHES AND MANAGEMENT ISSUES

DOI: https://doi.org/10.29296/25877305-2023-09-01
Issue: 
9
Year: 
2023

D. Blinov(1–3), Candidate of Medical Sciences; Professor A. Solopova(1), MD; Professor E. Achkasov(1), MD; L. Sandzhieva(1), D. Korabelnikov(3), Candidate
of Medical Sciences; G. Bykovshchenko(1), D. Petrenko(1),
1-I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
2-Institute of Preventive and Social Medicine, Moscow
3-F.P. Gaaz Moscow Sociomedical Institute

The incidence of oncogynecological pathologies, including endometrial cancer (EC), tends to increase, especially among women of reproductive age. Treatment of EC involves radical surgical intervention, as well as combined chemoradiotherapy according to indications, which has a traumatic effect on the physical, psycho-emotional, and social well-being of the patient. A comprehensive personalized rehabilitation program significantly improves the quality of life (QoL). However, the issue of introducing restorative measures into еру clinical practice remains open.
Keywords: 
endometrial cancer
quality of life
rehabilitation

References: 
  1. Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 2021; 18 (10): 663–72. DOI: 10.1038/s41571-021-00514-z
  2. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71 (3): 209–49. DOI: 10.3322/caac.21660
  3. Cостояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022; 239 с. [The state of oncological care for the Russian population in 2021. Eds. A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: Hertsen Moscow Oncology Research Center – Branch of National Medical Research Radiological Centre, 2022; 239 p. (in Russ.)].
  4. Lu K.H., Broaddus R.R. Endometrial Cancer. N Engl J Med. 2020; 383 (21): 2053–64. DOI: 10.1056/NEJMra1514010
  5. Doherty M.T., Sanni O.B., Coleman H.G. et al. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis. PLoS One. 2020; 15 (4): e0232231. DOI: 10.1371/journal.pone.0232231
  6. Son J., Carr C., Yao M., et al. Endometrial cancer in young women: prognostic factors and treatment outcomes in women aged ≤40 years. Int J Gynecol Cancer. 2020; 30 (5): 631–9. DOI: 10.1136/ijgc-2019-001105
  7. Aune D., Sen A., Vatten L.J. Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies [published correction appears in Sci Rep. 2018; 8: 46961]. Sci Rep. 2017; 7: 44808. DOI: 10.1038/srep44808
  8. Bahado-Singh R.O., Lugade A., Field J. et al. Metabolomic prediction of endometrial cancer. Metabolomics. 2017; 14 (1): 6. DOI: 10.1007/s11306-017-1290-z
  9. Bhaskaran K., Douglas I., Forbes H. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014; 384 (9945): 755–65. DOI: 10.1016/S0140-6736(14)60892-8
  10. Coll-de la Rubia E., Martinez-Garcia E., Dittmar G. et al. Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis. J Clin Med. 2020; 9 (6): 1900. DOI: 10.3390/jcm9061900
  11. Gao J., Tian J., Lv Y. et al. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 2009; 100 (3): 389–95. DOI: 10.1111/j.1349-7006.2008.01053.x
  12. Bokhman J.V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983; 15 (1): 10–7. DOI: 10.1016/0090-8258(83)90111-7
  13. Concin N., Matias-Guiu X., Vergote I. et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021; 31 (1): 12–39. DOI: 10.1136/ijgc-2020-002230
  14. Barretina-Ginesta M.P., Quindós M., Alarcón J.D. et al. SEOM-GEICO clinical guidelines on endometrial cancer (2021). Clin Transl Oncol. 2022; 24 (4): 625–34. DOI: 10.1007/s12094-022-02799-7
  15. Kokts-Porietis R.L., Elmrayed S., Brenner D.R. et al. Obesity and mortality among endometrial cancer survivors: A systematic review and meta-analysis. Obes Rev. 2021; 22 (12): e13337. Doi: 10.1111/obr.13337
  16. Клинические рекомендации Минздрава России. Рак тела матки и саркомы матки МКБ-10: C54. 2021 [Klinicheskie rekomendatsii Minzdrava Rossii. Rak tela matki i sarkomy matki MKB-10: C54. 2021 (in Russ.)]
  17. Блинов Д.В., Солопова А.Г., Ачкасов Е.Е. и др. Современный взгляд на реабилитацию пациенток с раком шейки матки. Акушерство, Гинекология и Репродукция. 2023; 17 (3): 343–56 [Blinov D.V., Solopova A.G., Achkasov E.E. et al. Contemporary insights into rehabilitation of cervical cancer patients. Obstetrics, Gynecology and Reproduction. 2023; 17 (3): 343–56 (in Russ.)]. DOI: 10.17749/2313-7347/ob.gyn.rep.2023.426
  18. Блинов Д.В., Солопова А.Г., Ачкасов Е.Е. и др. Организация реабилитации пациенток с опухолями яичников: современные подходы и будущие направления. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 16 (2): 303–16 [Blinov D.V., Solopova A.G., Achkasov E.E. et al. Strengthening rehabilitation for patients with ovarian tumors: current approaches and future directions. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023; 16 (2): 303–16 (in Russ.)]. DOI: 10.17749/2070-4909/farmakoekonomika.2023.196
  19. Falcone F., Laurelli G., Losito S. et al. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J Gynecol Oncol. 2017; 28 (1): e2. DOI: 10.3802/jgo.2017.28.e2
  20. Nees L.K., Heublein S., Steinmacher S. et al. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022; 306 (2): 407–21. DOI: 10.1007/s00404-021-06380-5
  21. Prip C.M., Stentebjerg M., Bennetsen M.H. et al. Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study. PLoS One. 2022; 17 (4): e0266339. DOI: 10.1371/journal.pone.0266339
  22. Auclair M.H., Yong P.J., Salvador S. et al. Guideline No. 390-Classification and Management of Endometrial Hyperplasia [published correction appears in J Obstet Gynaecol Can. 2020; 42 (10): 1287]. J Obstet Gynaecol Can. 2019; 41 (12): 1789–800. DOI: 10.1016/j.jogc.2019.03.025
  23. Нечушкина В.М., Коломиец Л. А., Кравец О. А. и др. Практические рекомендации по лекарственному лечению рака тела матки и сарком матки. Злокачественные опухоли. 2021; 3 (S2-1): 218–32 [Nechushkina V.M., Kolomiets L. A., Kravets O. A. et al. Prakticheskie rekomendatsii po lekarstvennomu lecheniyu raka tela matki i sarkom matki. Malignant Tumours. 2021; 3 (S2-1): 218–32 (in Russ.)]. DOI: 10.18027/2224-5057-2021 -11-3s2-14
  24. Санджиева Л.Н., Солопова А.Г., Блинов Д.В. и др. Персонифицированная программа комплексной реабилитации после хирургического лечения рака эндометрия: результаты проспективного рандомизированного сравнительного исследования. Акушерство, Гинекология и Репродукция. 2022; 16 (2): 143–57 [Sandzhieva L.N., Solopova A.G., Blinov D.V., Son E.A., Galkin V.N., Alekseev A.B. Personalized comprehensive rehabilitation program after surgical treatment of endometrial cancer: results of a prospective randomized comparative study. Obstetrics, Gynecology and Reproduction. 2022; 16 (2): 143–57 (in Russ.)]. DOI: 10.17749/2313-7347/ob.gyn.rep.2022.318
  25. Karataşli V., Can B., Çakir I., et al. Life quality of endometrioid endometrial cancer survivors: a cross-sectional study. J Obstet Gynaecol. 2020; 41 (4): 621–5. DOI: 10.1080/01443615.2020.1787969
  26. Солопова А.Г., Блинов Д.В., Бегович Е. и др. Неврологические расстройства после гистерэктомии: от патогенеза к клинике. Эпилепсия и пароксизмальные состояния. 2022; 14 (1): 54–64 [Solopova A.G., Blinov D.V., Begovich E. et al. Neurological disorders after hysterectomy: from pathogenesis to clinical manifestations. Epilepsy and paroxysmal conditions. 2022; 14 (1): 54–64 (in Russ.)]. DOI: 10.17749/2077-8333/epi.par.con.2022.115
  27. Zandbergen N., Rooij B., Vos C.M. et al. Changes in health-related quality of life among gynecologic cancer survivors during the two years after initial treatment: A longitudinal analysis. Acta Oncologica. 2019; 58 (5): 790–800. DOI: 10.1080/0284186X.2018.1560498.
  28. Lindqvist E., Wedin M., Fredrikson M. et al. Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol. 2017; 211: 112–21. DOI: 10.1016/j.ejogrb.2017.02.021
  29. Yost K.J., Cheville A.L., Al-Hilli M.M. et al. Lymphedema after surgery for endometrial cancer: prevalence, risk factors, and quality of life. Obstet Gynecol. 2014; 124 (2 Pt 1): 307–15. DOI: 10.1097/AOG.0000000000000372
  30. Nappi R.E., Palacios S., Panay N. et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2016; 19 (2): 188–97. DOI: 10.3109/13697137.2015.1107039
  31. Mac Bride M.B., Rhodes D.J., Shuster L.T. Vulvovaginal atrophy. Mayo Clin Proc. 2010; 85 (1): 87–94. DOI: 10.4065/mcp.2009.0413
  32. Ампилогова Д.М., Солопова А.Г., Блинов Д.В. и др. (2022). Вульвовагинальная атрофия: проблемы лечения и реабилитации. Гинекология. 2022; 24 (4): 240–5 [Ampilogova D.M., Solopova A.G., Blinov D.V. et al. Vulvovaginal atrophy: issues of treatment and rehabilitation: A review. Gynecology. 2022; 24 (4): 240–5 (in Russ.)]. DOI: 10.26442/20795696.2022.4.201792
  33. Podlasz P., Wasowicz K. Effect of partial hysterectomy on the neurons of the paracervical ganglion (PCG) of the pig. PLoS One. 2021; 16 (1): e0245974. DOI: 10.1371/journal.pone.0245974
  34. Cohn D.E., Castellon-Larios K., Huffman L. et al. A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer. J Minim Invasive Gynecol. 2016; 23 (3): 429–34. DOI: 10.1016/j.jmig.2016.01.002
  35. Lunde S., Nguyen H.T., Petersen K.K. et al. Chronic Postoperative Pain After Hysterectomy for Endometrial Cancer: A Metabolic Profiling Study. Mol Pain. 2020; 16: 1744806920923885. DOI: 10.1177/1744806920923885
  36. Turner T.B., Habib A.S., Broadwater G. et al. Postoperative Pain Scores and Narcotic Use in Robotic-assisted Versus Laparoscopic Hysterectomy for Endometrial Cancer Staging. J Minim Invasive Gynecol. 2015; 22 (6): 1004–10. DOI: 10.1016/j.jmig.2015.05.003
  37. Richards L., Healey M., Cheng C. et al. Laparoscopic oophorectomy to treat pelvic pain following ovary-sparing hysterectomy: factors associated with surgical complications and pain persistence. J Minim Invasive Gynecol. 2019; 26 (6): 1044–9. DOI: 10.1016/j. jmig.2018.10.005
  38. James S.K. Chronic postsurgical pain: is there a possible genetic link? Br J Pain. 2017; 11 (4): 178–85. DOI: 10.1177/2049463717723222
  39. Wiegel M., Meston C., Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005; 31 (1): 1–20. DOI: 10.1080/00926230590475206
  40. Блинов Д.В., Солопова А.Г., Плутницкий А.Н. и др. Организация здравоохранения в сфере реабилитации пациенток с онкологическими заболеваниями репродуктивной системы. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022; 15 (1): 119–30 [Blinov D.V., Solopova A.G., Plutnitskiy A.N. et al. Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022; 15 (1): 119–30 (in Russ.)]. DOI: 10.17749/2070-4909/farmakoekonomika.2022.132
  41. Yoder A.K., Lakomy D.S., Wu J. et al. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors. Clin Oncol (R Coll Radiol). 2023; 35 (2): e215-e226. DOI: 10.1016/j.clon.2022.11.010
  42. Gao H., Xiao M., Bai H. et al. Sexual Function and Quality of Life Among Patients With Endometrial Cancer After Surgery. Int J Gynecol Cancer. 2017; 27 (3): 608–12. DOI: 10.1097/IGC.0000000000000905
  43. Cho S.T., Kim K.H. Pelvic floor muscle exercise and training for coping with urinary incontinence. J Exerc Rehabil. 2021; 17 (6): 379–87. DOI: 10.12965/jer.2142666.333
  44. Bernard S., McLean L., Boucher S. et al. An in-home rehabilitation program for the treatment of urinary incontinence symptoms in endometrial cancer survivors: a single-case experimental design study. Int Urogynecol J. 2021; 32 (11): 2947–57. DOI: 10.1007/s00192-021-04981-x
  45. Koutoukidis D.A., Knobf M.T., Lanceley A. Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors. Nutr Rev. 2015; 73 (6): 399–408. DOI: 10.1093/nutrit/nuu063
  46. Конторщикова ЕЮ. Эффективность озонотерапии в комплексной реабилитации больных после оперативного лечения рака эндометрия. Физиотерапия, бальнеология и реабилитация. 2011; 10 (4): 30–3 [Kontorshchikova EY. The efficacy of ozonotherapy applied for the combined rehabilitative treatment of the patients following surgical management of endometrial cancer. Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2011; 10 (4): 30–3 (in Russ.)].
  47. de Pedro Negri A.M., Ruiz Prieto M.J., Diaz-Mohedo E. et al. Efficacy of Magnetic Therapy in Pain Reduction in Patients with Chronic Pelvic Pain: A Systematic Review. Int J Environ Res Public Health. 2022; 19 (10): 5824. DOI: 10.3390/ijerph19105824
  48. Buchanan A., Roddy M., Badr H. Patient-reported outcomes of non-pharmacological interventions for endometrial cancer survivors: a systematic review. J Cancer Surviv. 2021; 15 (4): 526–35. DOI: 10.1007/s11764-020-00946-z
  49. Солопова А.Г., Идрисова Л.Э., Макацария А.Д. и др. Мультидисциплинарный подход к медицинской реабилитации онкогинекологических больных. Акушерство, Гинекология и Репродукция. 2017; 11 (4): 57–67 [Solopova A.G., Idrisova L.E., Makatsariya A.D. et al. Multidisciplinary approach to medical rehabilitation of oncogynecologic patients. Obstetrics, Gynecology and Reproduction. 2017; 11 (4): 57–67 (in Russ.)]. DOI: 10.17749/2313-7347.2017.11.4.057-067
  50. Koutoukidis D.A., Beeken R.J., Lopes S. et al. Attitudes, challenges and needs about diet and physical activity in endometrial cancer survivors: a qualitative study. Eur J Cancer Care (Engl). 2017; 26 (6). DOI: 10.1111/ecc.12531
  51. Власина А.Ю., Идрисова Л.Э., Солопова А.Г. и др. Реабилитация онкогинекологических больных после противоопухолевой терапии: пути решения. Акушерство, Гинекология и Репродукция. 2020; 14 (1): 44–55 [Vlasina A.V., Idrisova L.E., Solopova A.G. et al. Rehabilitation of oncogynecological patients after antitumor therapy: ways of solution. Obstetrics, Gynecology and Reproduction. 2020; 14 (1): 44–55 (in Russ.)]. DOI: 10.17749/2313-7347.2020.14.1.44-55
  52. Anwar S.L., Adistyawan G., Wulaningsih W. et al. Rehabilitation for cancer survivors: how we can reduce the healthcare service inequality in low-and middle-income countries. Am J Phys Med Rehabil. 2018; 97 (10): 764–71. DOI: 10.1097/PHM.0000000000000982
  53. Almont T., Bujan L., Joachim C. et al. Collaborative digital platform France–Cuba: oncorehabilitation in reproductive and sexual health. BMC Medical Education. 2021; 21 (1): 1–8. DOI: 10.1186/s12909-021-02774-w